Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer

Cell Death and Disease(2022)10.1038/s41419-021-04495-wSource: DataRank Database

PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer is a research paper published in Cell Death and Disease (2022). On theSindex it has a DataRank of 0. It has been cited 32 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access32 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)OA: goldTopics (47)IDs (PubMed, PMC)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Alexandria N. Young,Andrew C. Huntsman,Melissa R. Pergande ORCID,Melissa A. Korkmaz ORCID,Rathnayake A. Rathnayake

Live enrichment

PubMed:35013112 PMC:PMC8748433

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: 1F30CA217079

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Grant: P01CA125066

NCI NIH HHS

Grant: F30 CA217079

National Institutes of Health

Grant: 5F30CA217079-04

FemKube, the human female reproductive tract-on-a-chip, as a platform for studying high grade serous ovarian cancer and developing novel cancer chemotherapeutics

National Institutes of Health

Grant: 3P01CA125066-09S1

DEVELOPING NEW SOURCES OF ANTICANCER DRUGS: ENDEMIC COASTAL MACROLICHENS AND THEIR ASCOMYCETES AND BASIDIOMYCETES MYCOBIONTS

U.S. Department of Health & Human Services | NIH | National Cancer Institute

goldLicense: cc-by

publisherhttps://www.nature.com/articles/s41419-021-04495-w.pdf

publisherhttps://www.nature.com/articles/s41419-021-04495-w

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8748433

repositoryhttps://doaj.org/article/e4c4de122bed46cdace434fd84397a5c

Europe_PMChttps://europepmc.org/articles/PMC8748433

Fields of Study

0301 basic medicine03 medical and health sciencesActive Transport, Cell NucleusAntineoplastic AgentsApoptosisAutophagyCell Line, TumorCell NucleusCellular Apoptosis Susceptibility ProteinCystadenocarcinoma, SerousFemaleHumansOvarian NeoplasmsPhyllanthusPrognosisProton-Translocating ATPases

MeSH Terms

Cell Line, TumorCell NucleusHumansPhyllanthusCystadenocarcinoma, SerousOvarian NeoplasmsProton-Translocating ATPasesCellular Apoptosis Susceptibility ProteinAntineoplastic AgentsPrognosisApoptosisActive Transport, Cell NucleusAutophagyFemale

Keywords

Cell NucleusOvarian NeoplasmsQH573-671Active Transport, Cell NucleusAntineoplastic AgentsApoptosisPrognosisArticleCystadenocarcinoma, SerousPhyllanthusProton-Translocating ATPasesCellular Apoptosis Susceptibility ProteinCell Line, TumorAutophagyHumansFemaleCytology

Sustainable Development Goals

SDG 3: 3. Good health

PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer

FAIR Checklist

Authors (18)

Funding (6 grants)

Open Access

Topics

Annotations (Europe PMC)